After you’ve collected your samples and secured a reliable sample management flow, what labs you choose for downstream analysis is one of the biggest questions to answer. When you consider how rigorous and specialized clinical trials have become around the world, how do you ensure your samples go to the right lab to get prepped and analyzed in time to keep your trial on track?
Laboratory diagnostic testing guides clinical decision-making for patient treatment and improves health outcomes. Access to routine and specialized testing with the ability to serve locations globally can be a crucial factor for successfully meeting the analytical requirements of your clinical trial protocol.
How do you choose labs that move fast enough in this complex environment for the lives that depend on them?
This webinar is part 3 of a multi-part series addressing key challenges facing sponsors of clinical trials and features an expert panel discussion. Join this webinar to gain valuable insights into how pathology & laboratory medicine can be vital in diagnosing, treating, and monitoring disease. Attendees will also learn how to accelerate their trial through advancements in molecular diagnostics, testing methodologies and automation.
Speakers
Ziad Peerwani, MD, Medical Director, Cleveland Clinic Laboratories
Ziad Peerwani, MD is the Medical Director of Cleveland Clinic Laboratories. He is triple board certified by the American Board of Pathology in anatomic pathology, clinical pathology and hematopathology.
Dr. Peerwani specializes in hematopathology and oversees Cleveland Clinic Laboratories, the outreach and reference laboratory services division of the Pathology & Laboratory Medicine Institute at Cleveland Clinic. He has an extensive history of hospital and laboratory leadership having served as Chairman at Tawam Hospital and Chief Executive Officer of Union 71, both in the United Arab Emirates. Additionally, Dr. Peerwani sits on several industry committees with the College of American Pathologists (CAP) and is the active Scientific Director for MEDLAB 2024 in Dubai. He is a co-author of many industry publications and abstracts in hematopathology, leukemia and lymphoma.
Hilmar Wisplinghoff, MD, Head of Microbiology, Labor Dr. Wisplinghoff
Hilmar Wisplinghoff is Professor of Microbiology at Witten/Herdecke University and head of Microbiology at Labor Dr. Wisplinghoff, one of the largest private diagnostic laboratories in Germany. He also works as an assessor for the German Accreditation Body (DAkkS), curator of the A. baumannii MLST database and Head of Microbiology for FungiScope. Clinically, he has trained and worked in medical microbiology, infection control and infectious diseases at the University of Cologne, Germany and Virginia Commonwealth University in Richmond, VA.
Hilmar Wisplinghoff has co-authored over 100 peer-reviewed publications. His current research interests include molecular epidemiology, NGS, AI and antimicrobial resistance.
Cindy Markham, Chief Commercial Officer, LabConnect
Cindy Markham has more than 25 years of leadership experience in public and private full-service CROs where she has led the global expansion of Phase II-IV business, along with business support functions, resulting in substantial organizational growth. She brings a deep understanding of customer challenges in drug development and is known for driving transformation. Cindy’s customer-centric approach is derived from experience in operations and commercial. She is passionate about serving customers and creating high-performing teams that do the same. Most recently, Cindy served as SVP, Commercial for PPD, a large and global CRO. She earned a master’s in public health from the University of North Carolina at Chapel Hill.
Who Should Attend?
This webinar will appeal to:
- Senior professionals working in clinical laboratory
- Clinical Operations Team Managers and Executives
- C Level Managers
What You Will Learn
Attendees will gain insights into:
- The importance of securing a reliable sample management flow as the foundation for downstream analysis in clinical trials
- Choosing the right laboratory for downstream analysis is a critical decision with far-reaching implications for clinical trials
- Ensuring that samples are prepped and analyzed in a timely manner to keep clinical trials on track, given the lives that depend on them
- How advancements in molecular diagnostics, testing methodologies and automation can accelerate the progress of clinical trials
- The broader role of pathology and laboratory medicine in the diagnosis, treatment and monitoring of various diseases
Xtalks Partner
LabConnect
LabConnect improves lives by partnering with pharma/biotech companies and clinical research organizations (CROs) to accelerate the development of medicines around the world. An independent, global, one-stop-shop focused on delivering central laboratory services that are tailor-made, timely and flexible to meet the evolving study demands of traditional and increasingly complex trials. With deep and unmatched experience, LabConnect’s team of scientific experts serves as an extension of our clients’ clinical teams, quickly coordinating all laboratory related needs and providing end-to-end analytical and logistical solutions.
Leading the evolution in central laboratory services since 2002, our services are tailored to fit the unique needs of your trial. Connect with us at www.labconnect.com or via email at [email protected].
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account